Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
For the full year, total product sales, excluding Veklury were $23.1 billion up 8% year over year, or 11%, excluding the impact of FX and the Truvada Atripla LOE, driven by HIV and oncology.
In 2016, when the estimated cost of Atripla in the developing world was around $100 per patient per year, the U.S. government paid $30,000 per patient per year for the same drug,” she said.
Source: https://leadership.ng/ahf-csos-tackle-us-firm-over-evergreening-patents-on-hiv-aids-drugs-others/